Home/Filings/5/0001214659-17-000746
5//SEC Filing

Anthera Pharmaceuticals Inc 5

Accession 0001214659-17-000746

CIK 0001316175operating

Filed

Feb 5, 7:00 PM ET

Accepted

Feb 6, 6:33 PM ET

Size

6.6 KB

Accession

0001214659-17-000746

Insider Transaction Report

Form 5
Period: 2016-12-31
Olson Charles V
CHIEF TECHNOLOGY OFFICER
Transactions
  • Award

    Common Stock

    2016-06-30$2.63/sh+1,789$4,7059,752 total
  • Award

    Common Stock

    2017-01-11$0.55/sh+7,767$4,27217,519 total
Footnotes (2)
  • [F1]Represents 1,789 shares acquired under the Issuer's 2010 Employee Stock Purchase Plan for the offering period ended June 30, 2016.
  • [F2]Represents 7,767 shares acquired under the Issuer's 2010 Employee Stock Purchase Plan for the offering period ended December 31, 2016.

Issuer

Anthera Pharmaceuticals Inc

CIK 0001316175

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001316175

Filing Metadata

Form type
5
Filed
Feb 5, 7:00 PM ET
Accepted
Feb 6, 6:33 PM ET
Size
6.6 KB